-
Crisis averted: NACDS, NCPA get their wish
WHAT IT MEANS AND WHY IT'S IMPORTANT — Retail pharmacies scored a big victory in the Centers for Medicare and Medicaid Services rule, which puts the kibosh on pricing policies that would have severely affected retail pharmacies' ability to make money from generic drugs, and thus forced them to turn away Medicaid patients.
-
Egrifta receives regulatory approval
SILVER SPRING, Md. The Food and Drug Administration has approved a drug for treating excess fat development in patients with HIV, the agency said Thursday.
The FDA approved Egrifta (tesamorelin) for treating HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, such as the abdominal organs. The condition is often a side effect of the retroviral drugs used to treat the disease.